Yu-Feng Tian

868 total citations
40 papers, 677 citations indexed

About

Yu-Feng Tian is a scholar working on Surgery, Molecular Biology and Epidemiology. According to data from OpenAlex, Yu-Feng Tian has authored 40 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 9 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Yu-Feng Tian's work include Renal Transplantation Outcomes and Treatments (5 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Yu-Feng Tian is often cited by papers focused on Renal Transplantation Outcomes and Treatments (5 papers), MicroRNA in disease regulation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Yu-Feng Tian collaborates with scholars based in Taiwan, China and Japan. Yu-Feng Tian's co-authors include Mao‐Tsun Lin, Cheng‐Hsien Lin, Ching-Yih Lin, Ming‐Jenn Chen, Chien‐Feng Li, Chung‐Hsi Hsing, Agnes L. F. Chan, Sung-Wei Lee, Mei-Hsuan Wu and Yu‐Ching Chou and has published in prestigious journals such as Free Radical Biology and Medicine, Journal of Clinical Pathology and World Journal of Gastroenterology.

In The Last Decade

Yu-Feng Tian

39 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu-Feng Tian Taiwan 17 243 134 131 130 125 40 677
Heng Fan China 17 348 1.4× 103 0.8× 177 1.4× 83 0.6× 72 0.6× 54 818
Zhihong Zhang China 13 159 0.7× 105 0.8× 68 0.5× 62 0.5× 94 0.8× 28 596
Martin F. Reiner Switzerland 17 152 0.6× 84 0.6× 45 0.3× 100 0.8× 123 1.0× 47 697
İbrahim Meteoğlu Türkiye 16 135 0.6× 79 0.6× 79 0.6× 153 1.2× 112 0.9× 72 688
S. Seber Türkiye 13 130 0.5× 97 0.7× 46 0.4× 84 0.6× 142 1.1× 56 516
Michelle Jankowski United States 16 195 0.8× 74 0.6× 128 1.0× 128 1.0× 126 1.0× 35 832
Lingyu Fu China 15 120 0.5× 131 1.0× 80 0.6× 54 0.4× 106 0.8× 55 765
Paola Vallerio Italy 16 228 0.9× 144 1.1× 34 0.3× 103 0.8× 86 0.7× 40 791
P. M. Ridker United States 9 165 0.7× 158 1.2× 48 0.4× 207 1.6× 81 0.6× 11 877
Marina Pauwels Belgium 15 398 1.6× 129 1.0× 60 0.5× 143 1.1× 126 1.0× 38 820

Countries citing papers authored by Yu-Feng Tian

Since Specialization
Citations

This map shows the geographic impact of Yu-Feng Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-Feng Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-Feng Tian more than expected).

Fields of papers citing papers by Yu-Feng Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu-Feng Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-Feng Tian. The network helps show where Yu-Feng Tian may publish in the future.

Co-authorship network of co-authors of Yu-Feng Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Yu-Feng Tian. A scholar is included among the top collaborators of Yu-Feng Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu-Feng Tian. Yu-Feng Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sun, Ding‐Ping, Yih‐Huei Uen, Chun‐Chao Chang, et al.. (2024). Punicalagin Restricts Growth, Promotes Apoptosis, and Reduces Invasion in Human Gastric Cancer Cells. Dose-Response. 22(2). 1516014906–1516014906. 5 indexed citations
3.
4.
Lin, Pei‐Yi, et al.. (2023). Incidentally portal vein penetration during cannulation in endoscopic retrograde cholangiopancreatography: a case report. Journal of Surgical Case Reports. 2023(6). rjad298–rjad298. 1 indexed citations
5.
Lee, Chung-Ta, Jenq-Chang Lee, Yi-Wen Wang, et al.. (2019). MiR-338-5p promotes metastasis of colorectal cancer by inhibition of phosphatidylinositol 3-kinase, catalytic subunit type 3-mediated autophagy pathway. EBioMedicine. 43. 270–281. 52 indexed citations
6.
Tian, Yu-Feng, et al.. (2018). Successful reuse of a transplanted kidney 9 years after initial transplantation: 4-year follow-up. BMC Nephrology. 19(1). 234–234. 4 indexed citations
7.
Chan, Pei‐Chi, et al.. (2017). Importance of NADPH oxidase-mediated redox signaling in the detrimental effect of CRP on pancreatic insulin secretion. Free Radical Biology and Medicine. 112. 200–211. 11 indexed citations
8.
Chio, Chung‐Ching, Chien‐Chin Hsu, Yu-Feng Tian, et al.. (2017). Combined Hemorrhagic Shock and Unilateral Common Carotid Occlusion Induces Neurological Injury in Adult Male Rats. International Journal of Medical Sciences. 14(13). 1327–1334. 6 indexed citations
9.
Huang, Steven K., et al.. (2016). Simultaneous Retroperitoneal Robotic Partial Nephrectomy and Hepatectomy for Synchronous Renal-Cell Carcinoma and Hepatocellular Carcinoma in a Cirrhotic Patient. Journal of Endourology Case Reports. 2(1). 215–217. 3 indexed citations
10.
Tian, Yu-Feng, et al.. (2016). Effect of Prolonged Diarrhea in Renal Transplant Recipients at a Single Center in Taiwan. Transplantation Proceedings. 48(3). 870–873. 2 indexed citations
11.
Tian, Yu-Feng, et al.. (2014). Repetitive hyperbaric oxygen therapy provides better effects on brain inflammation and oxidative damage in rats with focal cerebral ischemia. Journal of the Formosan Medical Association. 113(9). 620–628. 37 indexed citations
12.
Sun, Dingya, et al.. (2014). Renal Vein Stenosis With Transudative Ascites From Graft After Renal Transplantation With Good Response After Percutaneous Stent Placement. Transplantation Proceedings. 46(2). 598–601. 1 indexed citations
14.
Tian, Yu-Feng, Ching-Yih Lin, Li‐Tzong Chen, et al.. (2013). SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic target with high potential. Tumor Biology. 34(2). 1107–1117. 35 indexed citations
15.
Lin, Ching-Yih, Yu-Feng Tian, Li-Ching Wu, et al.. (2012). Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation. Journal of Clinical Pathology. 65(8). 687–692. 22 indexed citations
16.
Lan, Sheng‐Hui, et al.. (2012). Identification of colorectal cancer recurrence-related microRNAs. 4(1-2). 19–20. 6 indexed citations
17.
Lin, Ching-Yih, Chih-Chiang Chien, Wei‐Chih Kan, et al.. (2012). Impact of uremic environment on peritoneum: A proteomic view. Journal of Proteomics. 75(7). 2053–2063. 10 indexed citations
18.
Chan, Agnes L. F., et al.. (2008). Effects of Pharmaceutical Care Intervention by Clinical Pharmacists in Renal Transplant Clinics. Transplantation Proceedings. 40(7). 2319–2323. 47 indexed citations
19.
Tian, Yu-Feng, et al.. (2007). Major complications of operative gynecologic laparoscopy in Southern Taiwan: A follow-up study. Journal of Minimally Invasive Gynecology. 14(3). 284–292. 27 indexed citations
20.
Tian, Yu-Feng, Chi-Hong Chu, Mei-Hsuan Wu, et al.. (2007). Anthropometric measures, plasma adiponectin, and breast cancer risk. Endocrine Related Cancer. 14(3). 669–677. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026